EUVIMEDEUVIMED entdecken
Crossref

Flexible Dexamethasone-Eluting Cochlear implant electrode – longterm results

Thomas Lenarz, Rolf Salcher, Andreas Büchner, Daniel Kley, Nils Prenzler

Laryngo-Rhino-Otologie · 01.05.2024 · 103 (S 02 S 02) · S179

DOI: 10.1055/s-0044-1784570 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Laryngo-Rhino-Otologie, erschienen am 01.05.2024. Verfasst von Thomas Lenarz und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Indroduction Cochlear implantation should be as atraumatic as possible to preserve the cochlear structures aiming for the best outcomes with the CI. Flexible electrodes were developed and allow hearing preservation today. By augmenting the current electrode design with pharmaceutical therapies, the immune reaction can be reduced, which can support the preservation of the intracochlear structures.

Methods

In a first-in-human study, nine patients with some residual hearing received a cochlear implant with a flexible dexamethasone-eluting electrode of 28 mm length (FLEX28DEX). During the study, safety, electrode impedance, unaided pre-and postoperative hearing thresholds, speech intelligibility in noise and the surgeon"s subjective feedback were evaluated up to 9 months post activation. After the end of the study, patients" impedances and hearing thresholds were followed-up in the clinical routine up to 24 months.

Results

Handling and insertion properties of FLEX28 DEX were considered almost identical compared to a non-eluting FLEX28 by experienced surgeons. No serious device or procedure-related adverse events occurred throughout the complete follow-up period of the study. Study results (9 months post activation) showed remarkable low and stable impedance values and good hearing preservation in most patients. Up to 24 months the impedance values of FLEX28 DEX increased slightly but remained lower compared to regular FLEX28 of our clinic. Patients with FLEX28 DEX showed stable hearing preservation results up to 24 months post activation.

Conclusions

The use of the FLEX28 DEX was safe and showed better hearing preservation compared to results of our clinic of a non-eluting FLEX28 up to 24 months post activation. In future studies, also patients it the treatment of EAS candidates should be further investigated. Publication History Article published online: 19 April 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Lenarz, T., Salcher, R., Büchner, A., Kley, D., & Prenzler, N. (2024). Flexible Dexamethasone-Eluting Cochlear implant electrode – longterm results. Laryngo-Rhino-Otologie, 103(S 02 S 02), S179. https://doi.org/10.1055/s-0044-1784570

Vancouver

Lenarz T, Salcher R, Büchner A, Kley D, Prenzler N. Flexible Dexamethasone-Eluting Cochlear implant electrode – longterm results. Laryngo-Rhino-Otologie. 2024;103(S 02 S 02):S179. doi:10.1055/s-0044-1784570

BibTeX
@article{Lenarz2024,
  author = {Lenarz, Thomas and Salcher, Rolf and Büchner, Andreas and Kley, Daniel and Prenzler, Nils},
  title = {Flexible Dexamethasone-Eluting Cochlear implant electrode – longterm results},
  journal = {Laryngo-Rhino-Otologie},
  year = {2024},
  volume = {103},
  number = {S 02 S 02},
  pages = {S179},
  doi = {10.1055/s-0044-1784570}
}
Kostenlos starten →